We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
251
Elevance Health
ELV
$85.5B
$1.78M 0.05%
5,558
+891
+19% +$273K
ENPH icon
252
Enphase Energy
ENPH
$5.53B
$1.77M 0.05%
10,113
+979
+11% +$124K
AGG icon
253
iShares Core US Aggregate Bond ETF
AGG
$138B
$1.77M 0.05%
+14,988
New +$1.77M
IAU icon
254
iShares Gold Trust
IAU
$67.5B
$1.76M 0.05%
48,654
+10,232
+27% +$366K
MAT icon
255
Mattel
MAT
$4.23B
$1.76M 0.05%
100,953
-42,580
-30% -$627K
IPHI
256
DELISTED
INPHI CORPORATION
IPHI
$1.76M 0.05%
10,954
+7,005
+177% +$984K
CSGP icon
257
CoStar Group
CSGP
$12.3B
$1.75M 0.05%
18,990
+12,000
+172% +$1.05M
EHC icon
258
Encompass Health
EHC
$12.4B
$1.74M 0.05%
26,484
-15,691
-37% -$923K
COP icon
259
ConocoPhillips
COP
$141B
$1.74M 0.05%
43,519
+24,302
+126% +$896K
BDX icon
260
Becton Dickinson
BDX
$48.2B
$1.74M 0.05%
7,123
-2,688
-27% -$627K
SBAC icon
261
SBA Communications
SBAC
$19.5B
$1.74M 0.05%
6,163
-57
-0.9% -$16.7K
MANH icon
262
Manhattan Associates
MANH
$11.4B
$1.72M 0.05%
16,382
-3,765
-19% -$371K
CB icon
263
Chubb
CB
$135B
$1.72M 0.05%
11,189
+928
+9% +$130K
KMB icon
264
Kimberly-Clark
KMB
$36.5B
$1.72M 0.05%
12,758
+4,139
+48% +$579K
EMN icon
265
Eastman Chemical
EMN
$8.42B
$1.72M 0.05%
17,097
+9,104
+114% +$844K
RRX icon
266
Regal Rexnord
RRX
$11.9B
$1.7M 0.05%
13,882
-591
-4% -$65.3K
HUM icon
267
Humana
HUM
$46.2B
$1.7M 0.05%
4,146
+1,849
+80% +$769K
KLAC icon
268
KLA
KLAC
$259B
$1.7M 0.05%
65,710
-1,350
-2% -$31.5K
XYZ
269
Block Inc
XYZ
$47.5B
$1.7M 0.05%
7,815
-4,971
-39% -$970K
WSM icon
270
Williams-Sonoma
WSM
$29.6B
$1.7M 0.05%
33,300
+16,928
+103% +$867K
SO icon
271
Southern Company
SO
$107B
$1.69M 0.05%
27,524
+1,778
+7% +$107K
JAZZ icon
272
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.69M 0.05%
10,224
+3,848
+60% +$573K
MRSH
273
Marsh
MRSH
$91.5B
$1.68M 0.05%
14,385
-1,863
-11% -$212K
TRMB icon
274
Trimble
TRMB
$13.9B
$1.68M 0.05%
25,176
-21,170
-46% -$1.22M
SYK icon
275
Stryker
SYK
$130B
$1.68M 0.05%
6,852
+915
+15% +$207K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.